Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities
Grant Mechanisms
Training & Career
   Development
Contracts Management
Review Committees

Funding News

Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

Contact Us
My Privacy

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

  Print-friendly version

   Email this page

Researchers at the National Institute of Neurological Disorders and Stroke (NINDS) seek families with DYT1 dystonia (the most common type of familial generalized dystonia) to participate in a study. The purpose of this study is to understand how the brain controls movement and how this process is altered in DYT1 dystonia.

Eligible subjects include those with DYT1 positive gene status with dystonia, DYT1 carriers who have positive gene status but have no symptoms of dystonia, and family members who are non-carriers. The study, which involves a painless technique called transcranial magnetic stimulation (TMS) and lasts approximately 1-2 hours, will take place at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. All study-related expenses will be paid by the NIH.

For more information, physicians should contact Dr. Fiona Molloy, Office of the Clinical Director, NINDS, NIH, Building 10, Room 5N236, 10 Center Drive MSC 1428, Bethesda, Maryland 20892-1428, telephone: 301-594-0937.

---

This content has been adapted from the original NINDS Notes publication. For the most up-to-date funding information, please visit the Funding Opportunities section of the NINDS web site.  For the most recent information on NINDS studies, please visit the NINDS Patient Recruitment web site.